APA (7th ed.) Citation

HW, L., WJ, P., YR, H., TI, P., SY, P., & JH, L. (2017). TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma. OncoTargets and therapy, 10, 4853. https://doi.org/10.2147/OTT.S138956

Chicago Style (17th ed.) Citation

HW, Lee, Park WJ, Heo YR, Park TI, Park SY, and Lee JH. "TERT-CLPTM1 Locus Polymorphism (rs401681) Is Associated with the Prognosis of Hepatocellular Carcinoma." OncoTargets and Therapy 10 (2017): 4853. https://doi.org/10.2147/OTT.S138956.

MLA (9th ed.) Citation

HW, Lee, et al. "TERT-CLPTM1 Locus Polymorphism (rs401681) Is Associated with the Prognosis of Hepatocellular Carcinoma." OncoTargets and Therapy, vol. 10, 2017, p. 4853, https://doi.org/10.2147/OTT.S138956.